Akebia Therapeutics is a biopharmaceutical company with the purpose to better the life of each person impacted by kidney disease. We have both a commercially available product and a potential first-in-class product candidate for the treatment of anemia due to chronic kidney disease. We are located in the biotech hub of Cambridge, Massachusetts, where we are inspired by our peers and dedicated to working with our partners, patients, advocacy organizations and the broader kidney community.
Hope Week 2022 Exhibit Booth - Akebia Therapeutics
Read Akebia’s Information about Iron Deficiency Anemia and Hyperphosphatemia (High Phosphorus). Click the buttons below each image to view the 2-page PDF.
Follow Akebia on Social Media